nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—NPY1R—uterine cervix—cervical cancer	0.0418	0.136	CbGeAlD
Duloxetine—NPY1R—renal system—cervical cancer	0.0391	0.127	CbGeAlD
Duloxetine—NPY1R—mammalian vulva—cervical cancer	0.0365	0.119	CbGeAlD
Duloxetine—NPY1R—female reproductive system—cervical cancer	0.0313	0.102	CbGeAlD
Duloxetine—Rash erythematous—Topotecan—cervical cancer	0.0302	0.0437	CcSEcCtD
Duloxetine—Rigors—Topotecan—cervical cancer	0.0284	0.041	CcSEcCtD
Duloxetine—NPY1R—vagina—cervical cancer	0.0283	0.092	CbGeAlD
Duloxetine—Blood bilirubin increased—Topotecan—cervical cancer	0.0245	0.0354	CcSEcCtD
Duloxetine—Colitis—Topotecan—cervical cancer	0.0222	0.0321	CcSEcCtD
Duloxetine—Ear pain—Topotecan—cervical cancer	0.0197	0.0285	CcSEcCtD
Duloxetine—NPY1R—lymph node—cervical cancer	0.0183	0.0595	CbGeAlD
Duloxetine—Lethargy—Topotecan—cervical cancer	0.0172	0.0248	CcSEcCtD
Duloxetine—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0151	0.0219	CcSEcCtD
Duloxetine—Cramp muscle—Topotecan—cervical cancer	0.0151	0.0219	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0148	0.0214	CcSEcCtD
Duloxetine—SLC6A2—decidua—cervical cancer	0.0135	0.0439	CbGeAlD
Duloxetine—Weight increased—Topotecan—cervical cancer	0.0132	0.0191	CcSEcCtD
Duloxetine—Infestation NOS—Topotecan—cervical cancer	0.013	0.0187	CcSEcCtD
Duloxetine—Infestation—Topotecan—cervical cancer	0.013	0.0187	CcSEcCtD
Duloxetine—HTR2C—female reproductive system—cervical cancer	0.0127	0.0414	CbGeAlD
Duloxetine—Stomatitis—Topotecan—cervical cancer	0.0126	0.0182	CcSEcCtD
Duloxetine—Hepatobiliary disease—Topotecan—cervical cancer	0.0123	0.0177	CcSEcCtD
Duloxetine—Epistaxis—Topotecan—cervical cancer	0.0122	0.0177	CcSEcCtD
Duloxetine—SLC6A4—female reproductive system—cervical cancer	0.0121	0.0392	CbGeAlD
Duloxetine—Haemoglobin—Topotecan—cervical cancer	0.0117	0.0169	CcSEcCtD
Duloxetine—Haemorrhage—Topotecan—cervical cancer	0.0116	0.0168	CcSEcCtD
Duloxetine—Hypoaesthesia—Topotecan—cervical cancer	0.0116	0.0167	CcSEcCtD
Duloxetine—Pharyngitis—Topotecan—cervical cancer	0.0115	0.0167	CcSEcCtD
Duloxetine—SLC6A2—female reproductive system—cervical cancer	0.0106	0.0345	CbGeAlD
Duloxetine—Angiopathy—Topotecan—cervical cancer	0.0106	0.0152	CcSEcCtD
Duloxetine—Immune system disorder—Topotecan—cervical cancer	0.0105	0.0152	CcSEcCtD
Duloxetine—Mediastinal disorder—Topotecan—cervical cancer	0.0105	0.0151	CcSEcCtD
Duloxetine—Chills—Topotecan—cervical cancer	0.0104	0.0151	CcSEcCtD
Duloxetine—Alopecia—Topotecan—cervical cancer	0.0103	0.0149	CcSEcCtD
Duloxetine—CYP1A2—renal system—cervical cancer	0.0102	0.0331	CbGeAlD
Duloxetine—Malnutrition—Topotecan—cervical cancer	0.0101	0.0146	CcSEcCtD
Duloxetine—Back pain—Topotecan—cervical cancer	0.0098	0.0142	CcSEcCtD
Duloxetine—Muscle spasms—Topotecan—cervical cancer	0.00974	0.0141	CcSEcCtD
Duloxetine—Ill-defined disorder—Topotecan—cervical cancer	0.0094	0.0136	CcSEcCtD
Duloxetine—Anaemia—Topotecan—cervical cancer	0.00936	0.0135	CcSEcCtD
Duloxetine—Angioedema—Topotecan—cervical cancer	0.00925	0.0134	CcSEcCtD
Duloxetine—Malaise—Topotecan—cervical cancer	0.00913	0.0132	CcSEcCtD
Duloxetine—Leukopenia—Topotecan—cervical cancer	0.00906	0.0131	CcSEcCtD
Duloxetine—Cough—Topotecan—cervical cancer	0.00884	0.0128	CcSEcCtD
Duloxetine—Myalgia—Topotecan—cervical cancer	0.00862	0.0125	CcSEcCtD
Duloxetine—Chest pain—Topotecan—cervical cancer	0.00862	0.0125	CcSEcCtD
Duloxetine—Arthralgia—Topotecan—cervical cancer	0.00862	0.0125	CcSEcCtD
Duloxetine—HTR2A—epithelium—cervical cancer	0.0086	0.0279	CbGeAlD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00856	0.0124	CcSEcCtD
Duloxetine—Discomfort—Topotecan—cervical cancer	0.00852	0.0123	CcSEcCtD
Duloxetine—Anaphylactic shock—Topotecan—cervical cancer	0.00826	0.0119	CcSEcCtD
Duloxetine—Infection—Topotecan—cervical cancer	0.00821	0.0119	CcSEcCtD
Duloxetine—Nervous system disorder—Topotecan—cervical cancer	0.0081	0.0117	CcSEcCtD
Duloxetine—Thrombocytopenia—Topotecan—cervical cancer	0.00809	0.0117	CcSEcCtD
Duloxetine—Skin disorder—Topotecan—cervical cancer	0.00803	0.0116	CcSEcCtD
Duloxetine—Hyperhidrosis—Topotecan—cervical cancer	0.00799	0.0115	CcSEcCtD
Duloxetine—HTR2A—renal system—cervical cancer	0.00797	0.0259	CbGeAlD
Duloxetine—Anorexia—Topotecan—cervical cancer	0.00788	0.0114	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00753	0.0109	CcSEcCtD
Duloxetine—Paraesthesia—Topotecan—cervical cancer	0.00742	0.0107	CcSEcCtD
Duloxetine—Dyspepsia—Topotecan—cervical cancer	0.00727	0.0105	CcSEcCtD
Duloxetine—CYP2D6—renal system—cervical cancer	0.00726	0.0236	CbGeAlD
Duloxetine—Decreased appetite—Topotecan—cervical cancer	0.00718	0.0104	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Topotecan—cervical cancer	0.00714	0.0103	CcSEcCtD
Duloxetine—Fatigue—Topotecan—cervical cancer	0.00713	0.0103	CcSEcCtD
Duloxetine—Constipation—Topotecan—cervical cancer	0.00707	0.0102	CcSEcCtD
Duloxetine—Pain—Topotecan—cervical cancer	0.00707	0.0102	CcSEcCtD
Duloxetine—Feeling abnormal—Topotecan—cervical cancer	0.00681	0.00984	CcSEcCtD
Duloxetine—Gastrointestinal pain—Topotecan—cervical cancer	0.00676	0.00976	CcSEcCtD
Duloxetine—Urticaria—Topotecan—cervical cancer	0.00657	0.00949	CcSEcCtD
Duloxetine—Abdominal pain—Topotecan—cervical cancer	0.00653	0.00944	CcSEcCtD
Duloxetine—Body temperature increased—Topotecan—cervical cancer	0.00653	0.00944	CcSEcCtD
Duloxetine—HTR2A—female reproductive system—cervical cancer	0.00639	0.0207	CbGeAlD
Duloxetine—SLC6A2—lymph node—cervical cancer	0.00622	0.0202	CbGeAlD
Duloxetine—Hypersensitivity—Topotecan—cervical cancer	0.00609	0.0088	CcSEcCtD
Duloxetine—Asthenia—Topotecan—cervical cancer	0.00593	0.00857	CcSEcCtD
Duloxetine—Pruritus—Topotecan—cervical cancer	0.00585	0.00845	CcSEcCtD
Duloxetine—CYP2D6—female reproductive system—cervical cancer	0.00582	0.0189	CbGeAlD
Duloxetine—HTR2A—vagina—cervical cancer	0.00578	0.0188	CbGeAlD
Duloxetine—Diarrhoea—Topotecan—cervical cancer	0.00565	0.00817	CcSEcCtD
Duloxetine—Dizziness—Topotecan—cervical cancer	0.00547	0.0079	CcSEcCtD
Duloxetine—CYP2D6—female gonad—cervical cancer	0.00529	0.0172	CbGeAlD
Duloxetine—Vomiting—Topotecan—cervical cancer	0.00525	0.00759	CcSEcCtD
Duloxetine—Rash—Topotecan—cervical cancer	0.00521	0.00753	CcSEcCtD
Duloxetine—Dermatitis—Topotecan—cervical cancer	0.00521	0.00752	CcSEcCtD
Duloxetine—Headache—Topotecan—cervical cancer	0.00518	0.00748	CcSEcCtD
Duloxetine—Nausea—Topotecan—cervical cancer	0.00491	0.00709	CcSEcCtD
